近年来,由于生活方式的改变以及糖尿病、高血压等慢性疾病,早产数量有所增加。据联合国机构和合作伙伴称,预计 2020 年将有 1340 万婴儿早产,其中近 100 万人死于与早产相关的问题。这意味着全球大约十分之一的婴儿早产(怀孕 37 周之前)。早产儿可能会出现呼吸问题、喂养困难、发育迟缓以及视力和听力问题。
早产儿数量的增加导致对母乳强化剂的需求激增,以确保母乳强化剂的正常生长。婴儿的生长发育。许多早产儿需要在母乳中添加额外的营养。他们通常需要额外的蛋白质、钙、磷,甚至盐来构建强壮的骨骼和健康的器官。母乳强化剂有助于为婴儿提供这些额外的营养。在母乳强化剂中,在喂给婴儿之前,会在母乳中添加额外的营养物质。
因此,早产数量的激增正在支撑欧洲母乳的发展强化剂市场增长。
与其他地区一样,欧洲早产率也有所上升。在许多欧洲国家,女性出现推迟生育和高龄怀孕的趋势。该因素导致早产风险较高。此外,某些生活方式因素,如吸烟、饮酒、吸毒和产前护理不足,也会导致早产风险增加。所有这些因素导致早产增加,这反过来又增加了该地区对母乳强化剂的需求。
欧洲母乳强化剂市场细分
欧洲母乳强化剂市场根据形式、分销渠道和国家进行细分。根据形式,欧洲母乳强化剂市场分为粉末和液体。到2023年,奶粉细分市场将占据更大的市场份额。
从分销渠道来看,欧洲母乳强化剂市场分为线上和线下。 2023年,线下细分市场占据更大的市场份额。
按国家划分,欧洲母乳强化剂市场分为德国、意大利、法国、英国、俄罗斯和欧洲其他地区。 2023 年,欧洲其他地区将主导欧洲母乳强化剂市场份额。
雅培 (Abbott Laboratories)、雀巢 (Nestle SA)、Prolacta Bioscience Inc、Raptakos、Brett & Co. Co Ltd、NeoKare Nutrition Ltd、Danone SA、Neolac Inc 和 Reckitt Benckiser Group Plc 是欧洲母乳强化剂市场上的一些领先公司。
Strategic insights for Europe Human Milk Fortifier involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 82.62 Million |
Market Size by 2030 | US$ 150.86 Million |
Global CAGR (2023 - 2030) | 9.0% |
Historical Data | 2021-2022 |
Forecast period | 2024-2030 |
Segments Covered |
By 形态
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Human Milk Fortifier refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Human Milk Fortifier Market is valued at US$ 82.62 Million in 2023, it is projected to reach US$ 150.86 Million by 2030.
As per our report Europe Human Milk Fortifier Market, the market size is valued at US$ 82.62 Million in 2023, projecting it to reach US$ 150.86 Million by 2030. This translates to a CAGR of approximately 9.0% during the forecast period.
The Europe Human Milk Fortifier Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Human Milk Fortifier Market report:
The Europe Human Milk Fortifier Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Human Milk Fortifier Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Human Milk Fortifier Market value chain can benefit from the information contained in a comprehensive market report.